In vitro inhibition of mumps virus replication by favipiravir (T-705).

Lawson, Benton; Suppiah, Suganthi; Rota, Paul A; Hickman, Carole J; Latner, Donald R

Lawson, Benton; Suppiah, Suganthi; Rota, Paul A; Hickman, Carole J; Latner, Donald R.

Afiliação

Lawson B; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Suppiah S; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Rota PA; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hickman CJ; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Latner DR; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: dlatner@hudsonalpha.org.

Antiviral Res ; 180: 104849, 2020 08.

Article em En | MEDLINE | ID: mdl-32553844

Assuntos

Amidas/farmacologia; Antivirais/farmacologia; Vírus da Caxumba/efeitos dos fármacos; Pirazinas/farmacologia; Replicação Viral/efeitos dos fármacos; Células A549; Animais; Chlorocebus aethiops; Humanos; RNA Viral/antagonistas & inibidores; Células Vero

Palavras-chave

Anti-viral; Favipiravir; MMR; Mumps; Paramyxovirus; T-705

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Pirazinas / Replicação Viral / Amidas / Vírus da Caxumba Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google